Jordana Jampel

DocwireNews

Researchers led by Bei-Si Lin investigated the predictive accuracy of hemoglobin glycation index (HGI) time-in-range (TIR) &gt;70% hypoglycemia in patients with type 2 diabetes (T2D), which could offer new perspectives for the individualized treatment of patients with well-controlled blood glucose levels.
All participants (n=129) underwent 7-day continuous glucose monitoring (CGM) using a retrospective CGM system to obtain glycemic variability indices. HGI was defined as laboratory A1c minus the glucose management indicator. Participants were categorized into low-HGI (&lt;0.5) and high-HGI (≥0.5) groups according to HGI median (0.5).
Logistic regression and receiver operating characteristic curve analyses were used to determine the risk factors for hypoglycemia. The following data and findings were drawn:
<ul>
<li>The median age of the 129 participants was 54.84 ± 12.56 years, and 46% were men. The median TIR score was 90%.</li>
<li>The high-HGI group exhibited lower TIR and greater time below range with higher A1c than the low-HGI group, thus suggesting more glycemic excursion and an increased incidence of hypoglycemia in the high-HGI group.</li>
<li>Multivariate analyses revealed that mean blood glucose, standard deviation of blood glucose, and HGI were independent risk factors for hypoglycemia.</li>
<li>Receiver operating characteristic curve analysis indicated that the HGI was the best predictor of hypoglycemia.</li>
<li>The optimal cutoff points for HGI, mean blood glucose, and standard deviation of blood glucose in predicting hypoglycemia were 0.5%, 7.2 nmol/L, and 1.4 nmol/L, respectively.</li>
</ul>
Based on these findings, the researchers concluded that high HGI was significantly associated with greater glycemic excursions and increased hypoglycemia in patients with TIR &gt;70%. Therefore, HGI may be a reliable predictor of hypoglycemia in this population.

Laura Litwin

Circulating Tumor DNA Presence Associated With Consolidation Immunotherapy Outcomes in NSCLC

Non-Small Cell Lung Cancer

Positive Predictive Value of HGI on Hypoglycemia in T2D

Diabetes

BRCA Pathogenic Variants Detected by Neural Deep Learning Model

Breast Cancer

Latest News

The high-HGI group exhibited lower TIR and greater time below range with higher A1c than the low-HGI group.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Career Center

Expert Interviews

Subscribe